Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

Journal of Neural Transmission

Volumn 116, Issue 12, 2009, Pages 1591-1599

  Cozzi, Nicholas V ^a   Gopalakrishnan, Anupama ^a   Anderson, Lyndsey L ^a   Feih, Joel T ^a   Shulgin, Alexander T ^b   Daley, Paul F ^c   Ruoho, Arnold E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b St Luke's Campus ^*  (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Biogenic amine; Dihydrotetrabenazine; Diisopropyltryptamine; Dimethyltryptamine; Dipropyltryptamine; DIPT; DMT; DPT; Methylisopropyltryptamine; MIPT; Paroxetine; Psychedelic; Serotonin; Sigma 1 receptor; Tetrabenazine

Indexed keywords

N METHYL N ISOPROPYLTRYPTAMINE; N,N DIISOPROPYLTRYPTAMINE; N,N DIMETHYLTRYPTAMINE; N,N DIPROPYLTRYPTAMINE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SIGMA 1 OPIATE RECEPTOR; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTONIN UPTAKE; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL LINE; HALLUCINOGENS; HUMANS; N,N-DIMETHYLTRYPTAMINE; PAROXETINE; RATS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SPODOPTERA; TETRABENAZINE; TRITIUM; TRYPTAMINES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 70949104580     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0308-8     Document Type: Article

References (65)

1. EM Adkins EL Barker RD Blakely 2001 Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition Mol Pharmacol 59 514 523 1:CAS:528: DC%2BD3MXhs1Ojs7o%3D 11179447
2. B Angrist S Gershon G Sathananthan RW Walker B Lopez-Ramos LR Mandel WJ Vandenheuvel 1976 Dimethyltryptamine levels in blood of schizophrenic patients and control subjects Psychopharmacology (Berl) 47 29 32 10.1007/BF00428697 1:CAS:528:DyaE28XktFylsLY%3D
3. J Axelrod 1961 Enzymatic formation of psychotomimetic metabolites from normally occurring compounds Science 134 343 10.1126/science.134.3475.343 1:CAS:528:DyaF38Xot1CrsA%3D%3D 13685339
4. E Aydar CP Palmer VA Klyachko MB Jackson 2002 The sigma receptor as a ligand-regulated auxiliary potassium channel subunit Neuron 34 399 410 10.1016/S0896-6273(02)00677-3 1:CAS:528:DC%2BD38XjsFGgu7o%3D 11988171 (Pubitemid 34465498)
5. SA Barker JM Beaton ST Christian JA Monti PE Morris 1982 Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N,N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect Biochem Pharmacol 31 2513 2516 10.1016/0006-2952(82)90062-4 1:CAS:528:DyaL3sXotlWmsg%3D%3D 6812592
6. EL Barker HL Kimmel RD Blakely 1994 Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands Mol Pharmacol 46 799 807 1:CAS:528:DyaK2MXitlOmu74%3D 7969065
7. EL Barker KR Moore F Rakhshan RD Blakely 1999 Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter J Neurosci 19 4705 4717 1:CAS:528:DyaK1MXjvVCktrw%3D 10366604
8. OG Berge D Chacho K Hole 1983 Inhibitory effect of 5-methoxy-N,N- dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine Eur J Pharmacol 90 293 296 10.1016/0014-2999(83)90253-4 1:CAS:528:DyaL3sXks1Chs7g%3D 6873188
9. JF Brutcher W Vanderwerff 1958 Concerning a preparation of tryptamine J Org Chem 23 146 147 10.1021/jo01095a642 1:CAS:528:DyaG1cXhtVChsrc%3D
10. SA Burchett TP Hicks 2006 The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain Prog Neurobiol 79 223 246 10.1016/j.pneurobio.2006.07.003 1:CAS:528:DC%2BD28XhtVajsrjL 16962229 (Pubitemid 44427960)
11. JC Callaway DJ McKenna CS Grob GS Brito LP Raymon RE Poland EN Andrade EO Andrade DC Mash 1999 Pharmacokinetics of hoasca alkaloids in healthy humans J Ethnopharmacol 65 243 256 10.1016/S0378-8741(98)00168-8 1:CAS:528: DyaK1MXksVWhsbo%3D 10404423 (Pubitemid 29336019)
12. Y Cheng WH Prusoff 1973 Relationship between the inhibition constant (k1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem Pharmacol 22 3099 3108 10.1016/0006-2952(73) 90196-2 1:CAS:528:DyaE2cXhtVGgs7c%3D 4202581
13. L Corbett ST Christian RD Morin F Benington JR Smythies 1978 Hallucinogenic N-methylated indolealkylamines in the cerebrospinal fluid of psychiatric and control populations Br J Psychiatry 132 139 144 10.1192/bjp.132.2.139 1:CAS:528:DyaE1MXksFCisL8%3D 272218
14. NV Cozzi KF Foley 2002 Rapid and efficient method for suspending cells for neurotransmitter uptake assays Biotechniques 32 486 492 1:CAS:528: DC%2BD38XitFCnsrs%3D 11911651
15. D Crespi T Mennini M Gobbi 1997 Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4- methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine Br J Pharmacol 121 1735 1743 10.1038/sj.bjp.0701325 1:CAS:528:DyaK2sXlslaqtLc%3D 9283711 (Pubitemid 27343404)
16. 2 receptors Biochem Pharmacol 41 1739 1744 10.1016/0006-2952(91)90178-8 1:CAS:528: DyaK3MXkt1aqurk%3D 1828347
17. 2A receptors in rodents Pharmacol Biochem Behav 88 358 365 10.1016/j.pbb.2007.09.007 1:CAS:528:DC%2BD2sXhtlCru7jO 17905422 (Pubitemid 350123552)
18. D Fontanilla M Johannessen AR Hajipour NV Cozzi MB Jackson AE Ruoho 2009 The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator Science 323 934 937 10.1126/science.1166127 1:CAS:528: DC%2BD1MXhslSgsbw%3D 19213917
19. F Franzen H Gross 1965 Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxytryptamine in human blood and urine Nature 206 1052 10.1038/2061052a0 1:CAS:528:DyaF2MXktleqtrw%3D 5839067
20. RA Glennon SM Liebowitz EC Mack 1978 Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues J Med Chem 21 822 825 10.1021/jm00206a022 1:CAS:528: DyaE1cXkvF2ks78%3D 278843
21. T Hayashi TP Su 2003 Intracellular dynamics of σ-1 receptors (σ1 binding sites) in NG108-15 cells J Pharmacol Exp Ther 306 726 733 10.1124/jpet.103.051292 1:CAS:528:DC%2BD3sXlslGlu7g%3D 12730356 (Pubitemid 36886174)
22. T Hayashi TP Su 2007 Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival Cell 131 596 610 10.1016/j.cell.2007.08.036 1:CAS:528:DC%2BD2sXhtlWitrzK 17981125 (Pubitemid 350017760)
23. MS Jacob DE Presti 2005 Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine Med Hypotheses 64 930 937 10.1016/j.mehy.2004.11.005 1:CAS:528:DC%2BD2MXisVClsrk%3D 15780487 (Pubitemid 40385946)
24. JF Lipinski LR Mandel HS Ahn WJ Vanden Heuvel RW Walker 1974 Blood dimethyltryptamine concentrations in psychotic disorders Biol Psychiatry 9 89 91 1:CAS:528:DyaE2sXltFGksbY%3D 4616726
25. PJ Lupardus RA Wilke E Aydar CP Palmer Y Chen AE Ruoho MB Jackson 2000 Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP J Physiol 526 Pt 3 527 539 10.1111/j.1469-7793.2000.00527.x 1:CAS:528:DC%2BD3cXmsFWmtb4%3D 10922005
26. AJ Mandell M Morgan 1971 Indole(ethyl)amine N-methyltransferase in human brain Nat New Biol 230 85 87 1:CAS:528:DyaE3MXksVGjtLw%3D 5279043
27. 3H]paroxetine binding in rat brain J Neurochem 50 1783 1790 10.1111/j.1471-4159.1988.tb02479.x 1:CAS:528:DyaL1cXktlWqtbw%3D 2967349
28. TA Mavlyutov AE Ruoho 2007 Ligand-dependent localization and intracellular stability of sigma-1 receptors in CHO-K1 cells J Mol Signal 2 8 10.1186/1750-2187-2-8 17883859 (Pubitemid 350031741)
29. DJ McKenna DB Repke L Lo SJ Peroutka 1990 Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes Neuropharmacology 29 193 198 10.1016/0028-3908(90)90001-8 1:CAS:528:DyaK3cXktVSit7s%3D 2139186 (Pubitemid 20096380)
30. 3H]5-hydroxytryptamine Pharmacol Biochem Behav 38 505 512 10.1016/0091-3057(91)90005-M 1:CAS:528:DyaK3MXit1SktLc%3D 1829838
31. M Morgan AJ Mandell 1969 Indole(ethyl)amine N-methyltransferase in the brain Science 165 492 493 10.1126/science.165.3892.492 1:CAS:528: DyaF1MXks1Omtr4%3D 5793241
32. F Nagai R Nonaka K Satoh Hisashi Kamimura 2007 The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain Eur J Pharmacol 559 132 137 10.1016/j.ejphar.2006.11.075 1:CAS:528:DC%2BD2sXisVWgu7g%3D 17223101 (Pubitemid 46295399)
33. PJ Nelson G Rudnick 1979 Coupling between platelet 5-hydroxytryptamine and potassium transport J Biol Chem 254 10084 10089 1:CAS:528:DyaE1MXlsFGgu7o%3D 489585 (Pubitemid 10162029)
34. B Olivier W Soudijn I van Wijngaarden 2000 Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors Prog Drug Res 54 59 119 1:CAS:528:DC%2BD3cXkvVOlsr4%3D 10857386
35. MC Oon RM Murray R Rodnight MP Murphy JL Birley 1977 Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects Psychopharmacology (Berl) 54 171 175 10.1007/BF00426775 1:CAS:528:DyaE1cXhvFOrsg%3D%3D (Pubitemid 8172386)
36. ML Pochettino AR Cortella M Ruiz 1999 Hallucinogenic snuff from northwestern Argentina: microscopical identification of Anadenanthera colubrina var Cebil (fabaceae) in powdered archaeological material Econ Bot 53 127 132
37. W Reimann F Schneider 1993 The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity Gen Pharmacol 24 449 453 1:CAS:528:DyaK3sXisVyhu7s%3D 8482527
38. J Riba M Valle G Urbano M Yritia A Morte MJ Barbanoj 2003 Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics J Pharmacol Exp Ther 306 73 83 10.1124/jpet.103.049882 1:CAS:528:DC%2BD3sXkvF2ltbg%3D 12660312 (Pubitemid 36734359)
39. 3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci 53:PL267-PL272
40. RB Rothman MA Ayestas CM Dersch MH Baumann 1999 Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension Circulation 100 869 875 1:CAS:528: DyaK1MXlvFCmtbo%3D 10458725
41. RB Rothman MH Baumann CM Dersch DV Romero KC Rice FI Carroll JS Partilla 2001 Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 32 41 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3 1:CAS:528:DC%2BD3cXovFahsLg%3D 11071707 (Pubitemid 30949297)
42. JM Saavedra J Axelrod 1972 Psychotomimetic N-methylated tryptamines: formation in brain in vivo and in vitro Science 175 1365 1366 10.1126/science.175.4028.1365 1:CAS:528:DyaE38XhsFWmtrc%3D 5059565
43. S Sangiah MV Gomez EF Domino 1979 Accumulation of N,N-dimethyltryptamine in rat brain cortical slices Biol Psychiatry 14 925 936 1:CAS:528: DyaL3cXhtVequ7c%3D 41604
44. P Schloss DC Williams 1998 The serotonin transporter: a primary target for antidepressant drugs J Psychopharmacol 12 115 121 10.1177/026988119801200201 1:CAS:528:DyaK1cXltFGmt7c%3D 9694022 (Pubitemid 28312567)
45. Shulgin AT and Shulgin A (1997) TIHKAL: the continuation. Transform Press, Berkeley, CA 94712
46. AT Shulgin MF Carter 1980 N,N-diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity Commun Psychopharmacol 4 363 369 1:CAS:528: DyaL3MXlt1Khs7g%3D 6949674
47. MK Sievert DS Thiriot RH Edwards AE Ruoho 1998 High-efficiency expression and characterization of the synaptic-vesicle monoamine transporter from baculovirus-infected insect cells Biochem J 330 Pt 2 959 966 1:CAS:528:DyaK1cXit1Kntb8%3D 9480916
48. BR Sitaram L Lockett R Talomsin GL Blackman WR McLeod 1987 In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat Biochem Pharmacol 36 1509 1512 10.1016/0006-2952(87)90118-3 1:CAS:528:DyaL2sXkvV2hsL4%3D 3472526 (Pubitemid 17079563)
49. TE Smith H Weissbach S Udenfriend 1962 Studies on the mechanism of action of monoamine oxidase: metabolism of N,N-dimethyltryptamine and N,N-dimethyltryptamine-N-oxide Biochemistry 1 137 143 10.1021/bi00907a021 1:CAS:528:DyaF38XktVGqt7w%3D 13914428
50. JR Smythies RD Morin GB Brown 1979 Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry Biol Psychiatry 14 549 556 1:CAS:528: DyaE1MXlsFeksbo%3D 289421
51. ME Speeter WC Anthony 1954 The action of oxalyl chloride on indoles: a new approach to tryptamines J Am Chem Soc 76 6208 6210 10.1021/ja01652a113 1:CAS:528:DyaG2MXosVWrtQ%3D%3D
52. Strassman RJ (2001) DMT: the spirit molecule: a doctor's revolutionary research into the biology of near-death and mystical experiences. Park Street Press, Rochester, VT
53. RJ Strassman CR Qualls EH Uhlenhuth R Kellner 1994 Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale Arch Gen Psychiatry 51 98 108 1:CAS:528: DyaK2cXis1Sgs7c%3D 8297217
54. Su T-P, Hayashi T, Vaupel DB (2009) When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor. Sci Signal 2: pe12
55. 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions Int J Appl Radiat Isot 36 965 969 10.1016/0020-708X(85)90257-1 1:CAS:528:DyaL28XhvVanu7w%3D 3866749
56. J Talvenheimo PJ Nelson G Rudnick 1979 Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport J Biol Chem 254 4631 4635 1:CAS:528:DyaE1MXkvVeis70%3D 438209 (Pubitemid 9203493)
57. H Tanimukai R Ginther J Spaide JR Bueno HE Himwich 1970 Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients Br J Psychiatry 117 421 430 10.1192/bjp.117.539.421 1:STN:280:DyaE3M%2Fjs1eruw%3D%3D 5312352
58. DS Thiriot AE Ruoho 2001 Mutagenesis and derivatization of human vesicle monoamine transporter 2 (VMAT2). Cysteines identifies transporter domains involved in tetrabenazine binding and substrate transport J Biol Chem 276 27304 27315 10.1074/jbc.M103947200 1:CAS:528:DC%2BD3MXlsV2ju7Y%3D 11375404
59. MA Thompson E Moon UJ Kim J Xu MJ Siciliano RM Weinshilboum 1999 Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization Genomics 61 285 297 10.1006/geno.1999.5960 1:CAS:528:DyaK1MXntFWqs7g%3D 10552930
60. AD Weissman TP Su JC Hedreen ED London 1988 Sigma receptors in post-mortem human brains J Pharmacol Exp Ther 247 29 33 1:CAS:528: DyaL1cXmt1agtL4%3D 2845055
61. MR Whipple MG Reinecke FH Gage 1983 Inhibition of synaptosomal neurotransmitter uptake by hallucinogens J Neurochem 40 1185 1188 10.1111/j.1471-4159.1983.tb08113.x 1:CAS:528:DyaL3sXhsleitr0%3D 6131933 (Pubitemid 13163356)
62. RJ Wyatt JM Saavedra J Axelrod 1973 A dimethyltryptamine-forming enzyme in human blood Am J Psychiatry 130 754 760 1:CAS:528:DyaE3sXks1Chsrc%3D 4514540
63. 11C]dimethyltryptamine Eur J Nucl Med 12 141 146 1:CAS:528:DyaL1cXlt1Shug%3D%3D 3489620
64. M Yritia J Riba J Ortuno A Ramirez A Castillo Y Alfaro R de la Torre MJ Barbanoj 2002 Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of ayahuasca J Chromatogr B Analyt Technol Biomed Life Sci 779 271 281 10.1016/S1570-0232(02) 00397-5 1:CAS:528:DC%2BD38XovF2ntbY%3D 12361741 (Pubitemid 35279454)
65. H Zhang J Cuevas 2002 Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons J Neurophysiol 87 2867 2879 1:CAS:528:DC%2BD38XltFSks74%3D 12037190